Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Public ClinicalTrials.gov record NCT00676533. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cipro® XR Excellence in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this clinical trial was to determine the time to improvement of the signs and symptoms (eg, dysuria, frequency, urgency, gross hematuria, suprapubic pain, hesitancy, low back pain) of acute, uncomplicated, symptomatic, lower UTIs in women treated with Cipro XR 500 mg once daily for 3 days.
Study identification
- NCT ID
- NCT00676533
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 276 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2003
- Primary completion
- Not listed
- Completion
- Dec 31, 2003
- Last update posted
- Oct 13, 2013
2003 – 2004
United States locations
- U.S. sites
- 40
- U.S. states
- 18
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35205 | — |
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Montgomery | Alabama | 36106 | — |
| Not listed | Tallassee | Alabama | 36078 | — |
| Not listed | Chandler | Arizona | 85225-2909 | — |
| Not listed | Mesa | Arizona | 85201 | — |
| Not listed | Phoenix | Arizona | 85014 | — |
| Not listed | Tempe | Arizona | 85282 | — |
| Not listed | Fresno | California | 93710 | — |
| Not listed | Mission Hills | California | 91345 | — |
| Not listed | San Diego | California | 92117 | — |
| Not listed | San Diego | California | 92128 | — |
| Not listed | San Diego | California | 92182-4701 | — |
| Not listed | Yorba Linda | California | 92886 | — |
| Not listed | Avon | Connecticut | 06001 | — |
| Not listed | Chiefland | Florida | 32626 | — |
| Not listed | Gainesville | Florida | 32605 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Ocala | Florida | 34474 | — |
| Not listed | Tampa | Florida | 33607 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Atlanta | Georgia | 30342 | — |
| Not listed | Conyers | Georgia | 30094 | — |
| Not listed | Fayetteville | Georgia | 30214 | — |
| Not listed | Hayden | Idaho | 83835 | — |
| Not listed | Evansville | Indiana | 47713 | — |
| Not listed | Baltimore | Maryland | 21210 | — |
| Not listed | Millersville | Maryland | 21108-1571 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Elizabeth | New Jersey | 07202-3672 | — |
| Not listed | Camillus | New York | 13031 | — |
| Not listed | Eugene | Oregon | 97404 | — |
| Not listed | Feasterville | Pennsylvania | 19053 | — |
| Not listed | Simpsonville | South Carolina | 29681 | — |
| Not listed | Lake Jackson | Texas | 77566 | — |
| Not listed | Salt Lake City | Utah | 84109 | — |
| Not listed | Salt Lake City | Utah | 84121 | — |
| Not listed | Seattle | Washington | 98105-5221 | — |
| Not listed | Spokane | Washington | 99216 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00676533, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2013 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00676533 live on ClinicalTrials.gov.